Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-026935
Filing Date
2025-08-14
Accepted
2025-08-14 16:10:06
Documents
52
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atxi20250630_10q.htm   iXBRL 10-Q 1118506
2 EXHIBIT 31.1 ex_828811.htm EX-31.1 12897
3 EXHIBIT 31.2 ex_828812.htm EX-31.2 12874
4 EXHIBIT 32.1 ex_828813.htm EX-32.1 4965
5 EXHIBIT 32.2 ex_828814.htm EX-32.2 4933
  Complete submission text file 0001437749-25-026935.txt   4825877

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atxi-20250630.xsd EX-101.SCH 47449
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxi-20250630_cal.xml EX-101.CAL 21827
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20250630_def.xml EX-101.DEF 291288
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20250630_lab.xml EX-101.LAB 281407
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20250630_pre.xml EX-101.PRE 314858
55 EXTRACTED XBRL INSTANCE DOCUMENT atxi20250630_10q_htm.xml XML 649585
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

EIN.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 251219044
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)